|
1
|
Al Zeyadi M, Dimova I, Ranchich V, Rukova
B, Nesheva D, Hamude Z, Georgiev S, Petrov D and Toncheva D: Whole
genome microarray analysis in non-small cell lung cancer.
Biotechnol Biotechnol Equip. 29:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ni M, Shi XL, Qu ZG, Jiang H, Chen ZQ and
Hu J: Epithelial mesenchymal transition of non-small-cell lung
cancer cells A549 induced by SPHK1. Asian Pac J Trop Med.
8:142–146. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakai M, Shimokawa T, Kobayashi T,
Matsushima S, Yamada Y, Nakamura Y and Furukawa Y: Elevated
expression of C10orf3 (chromosome 10 open reading frame 3) is
involved in the growth of human colon tumor. Oncogene. 25:480–486.
2006.
|
|
4
|
Fabbro M, Zhou BB, Takahashi M, Sarcevic
B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y, et
al: Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome
protein, Cep55, is required for its recruitment to midbody and
cytokinesis. Dev Cell. 9:477–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao WM, Seki A and Fang G: Cep55, a
microtubule-bundling protein, associates with centralspindlin to
control the midbody integrity and cell abscission during
cytokinesis. Mol Biol Cell. 17:3881–3896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martinez-Garay I, Rustom A, Gerdes HH and
Kutsche K: The novel centrosomal associated protein CEP55 is
present in the spindle midzone and the midbody. Genomics.
87:243–253. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh PK, Srivastava AK, Rath SK, Dalela
D, Goel MM and Bhatt ML: Expression and clinical significance of
Centrosomal protein 55 (CEP55) in human urinary bladder
transitional cell carcinoma. Immunobiology. 220:103–108. 2015.
View Article : Google Scholar
|
|
8
|
Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ,
Tsou AP, Lee YC, Lin TC, Hsu SL, Lin WJ, et al: FLJ10540-elicited
cell transformation is through the activation of PI3-kinase/AKT
pathway. Oncogene. 26:4272–4283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W,
Xie K, Tang J, Zhang X, Wang L, et al: CEP55 contributes to human
gastric carcinoma by regulating cell proliferation. Tumour Biol.
35:4389–4399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Jin T, Dai X and Xu J:
Lentivirus-mediated knockdown of CEP55 suppresses cell
proliferation of breast cancer cells. Biosci Trends. 10:67–73.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen CH, Lai JM, Chou TY, Chen CY, Su LJ,
Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, et al: VEGFA
upregulates FLJ10540 and modulates migration and invasion of lung
cancer via PI3K/AKT pathway. PLoS One. 4:e50522009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang W, Liang Z and Li J: Inhibition of
rhotekin exhibits antitumor effects in lung cancer cells. Oncol
Rep. 35:2529–2534. 2016.PubMed/NCBI
|
|
13
|
Eskander RN, Randall LM, Sakai T, Guo Y,
Hoang B and Zi X: Flavokawain B, a novel, naturally occurring
chalcone, exhibits robust apoptotic effects and induces G2/M arrest
of a uterine leiomyosarcoma cell line. J Obstet Gynaecol Res.
38:1086–1094. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang W, Niu C, He W, Hou T, Sun X, Xu L
and Zhang Y: Upregulation of centrosomal protein 55 is associated
with unfavorable prognosis and tumor invasion in epithelial ovarian
carcinoma. Tumour Biol. 37:6239–6254. 2016. View Article : Google Scholar :
|
|
15
|
Chen CH, Shiu LY, Su LJ, Huang CY, Huang
SC, Huang CC, Yin YF, Wang WS, Tsai HT, Fang FM, et al: FLJ10540 is
associated with tumor progression in nasopharyngeal carcinomas and
contributes to nasopharyngeal cell proliferation, and metastasis
via osteopontin/CD44 pathway. J Transl Med. 10:932012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nguyen-Ba G and Vasseur P: Epigenetic
events during the process of cell transformation induced by
carcinogens (Review). Oncol Rep. 6:925–932. 1999.PubMed/NCBI
|
|
17
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cicenas J, Kalyan K, Sorokinas A, Jatulyte
A, Valiunas D, Kaupinis A and Valius M: Highlights of the latest
advances in research on CDK Inhibitors. Cancers (Basel).
6:2224–2242. 2014. View Article : Google Scholar
|
|
20
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: Roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Delattre M and Gönczy P: The arithmetic of
centrosome biogenesis. J Cell Sci. 117:1619–1630. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Srsen V and Merdes A: The centrosome and
cell proliferation. Cell Div. 1:262006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dejean LM, Martinez-Caballero S, Manon S
and Kinnally KW: Regulation of the mitochondrial apoptosis-induced
channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta.
1762:191–201. 2006. View Article : Google Scholar
|
|
24
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Tang N, Hadden TJ and Rishi AK:
Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta.
1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu SW, Andrabi SA, Wang H, Kim NS, Poirier
GG, Dawson TM and Dawson VL: Apoptosis-inducing factor mediates
poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad
Sci USA. 103:18314–18319. 2006. View Article : Google Scholar : PubMed/NCBI
|
